ADRA2A antibody (C-Term) (Magnetic Particles)
Quick Overview for ADRA2A antibody (C-Term) (Magnetic Particles) (ABIN1492950)
Target
See all ADRA2A AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- Human, mouse, rat. No cross reactivity with other proteins.
-
Cross-Reactivity (Details)
- No cross reactivity with other proteins.
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide corresponding to a sequence mapping near the C-terminal of human ADRA2, identical to the related rat and mouse sequence.
Type of Immunogen: Synthetic peptide
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- 1 mg/mL magnetic beads in PBS, pH 7.2, 0.05 mg sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Store at 4°C.
-
-
- ADRA2A (Alpha-2A Adrenergic Receptor (ADRA2A))
-
Alternative Name
- ADRA2A
-
Background
-
Name/Gene ID: ADRA2A
Subfamily: Adrenergic
Family: GPCR
Synonyms: ADRA2A, Alpha-2A adrenoreceptor, Alpha-2AAR, Alpha-2AAR subtype C10, ADRA2, ADRA2R, ADRAR, Adrenoceptor alpha 2A, Alpha 2a, Alpha(2A)-AR, Alpha2a, ALPHA2AAR, Alpha-2A adrenoceptor, Adrenergic alpha 2a receptor, Adrenergic alpha 2a receptor, Alpha-2A adrenergic receptor -
Gene ID
- 150
-
UniProt
- P08913
-
Pathways
- EGFR Signaling Pathway, Negative Regulation of Hormone Secretion, Carbohydrate Homeostasis, cAMP Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Negative Regulation of Transporter Activity
Target
-